Anacardic acid (6-pentadecylsalicylic acid) inhibits tumor angiogenesis by targeting Src/FAK/Rho GTpases signaling pathway

Journal of Pharmacology and Experimental Therapeutics

Volumn 339, Issue 2, 2011, Pages 403-411

  Wu, Yuanyuan ^a   He, Lijun ^a   Zhang, Li ^a   Chen, Jing ^a   Yi, Zhengfang ^a   Zhang, Jian ^c   Liu, Mingyao ^a,b   Pang, Xiufeng ^a  

^a EAST CHINA NORMAL UNIVERSITY   (China)

^b TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^c SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANACARDIC ACID; FOCAL ADHESION KINASE; PROTEIN KINASE P60; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL ADHESION; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; CORNEA NEOVASCULARIZATION; CYTOTOXICITY TEST; DRUG EFFICACY; DRUG MECHANISM; DRUG STRUCTURE; DRUG TARGETING; ENDOTHELIUM CELL; GROWTH INHIBITION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TREATMENT RESPONSE; TUMOR GROWTH; TUMOR VOLUME;

ANACARDIC ACIDS; ANGIOGENESIS INHIBITORS; ANIMALS; CELL PROLIFERATION; CHICK EMBRYO; CHORIOALLANTOIC MEMBRANE; CORNEAL NEOVASCULARIZATION; DOSE-RESPONSE RELATIONSHIP, DRUG; FOCAL ADHESION KINASE 1; GTP PHOSPHOHYDROLASES; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MALE; MICE; MICE, INBRED C57BL; MOLECULAR TARGETED THERAPY; NEOVASCULARIZATION, PATHOLOGIC; PROSTATIC NEOPLASMS; PROTEIN-TYROSINE KINASES; RHO GTP-BINDING PROTEINS; RHO-ASSOCIATED KINASES; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES; TIME FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 80054785586     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.111.181891     Document Type: Article

References (48)

1. Acevedo HR, Rojas MD, Arceo SD, Soto Hernández M, Martínez Vázquez M, Terrazas T, and del Toro GV (2006) Effect of 6-nonadecyl salicylic acid and its methyl ester on the induction of micronuclei in polychromatic erythrocytes in mouse peripheral blood. Mutat Res 609:43-46. (Pubitemid 44339578)
2. Agochiya M, Brunton VG, Owens DW, Parkinson EK, Paraskeva C, Keith WN, and Frame MC (1999) Increased dosage and amplification of the focal adhesion kinase gene in human cancer cells. Oncogene 18:5646-5653. (Pubitemid 29497599)
3. Balasubramanyam K, Swaminathan V, Ranganathan A, and Kundu TK (2003) Small molecule modulators of histone acetyltransferase p300. J Biol Chem 278:19134-19140. (Pubitemid 36799302)
4. Bolós V, Gasent JM, López-Tarruella S, and Grande E (2010) The dual kinase complex FAK-Src as a promising therapeutic target in cancer. Onco Targets Ther 3:83-97.
5. Boureux A, Vignal E, Faure S, and Fort P (2007) Evolution of the Rho family of ras-like GTPases in eukaryotes. Mol Biol Evol 24:203-216. (Pubitemid 46026295)
6. Brown MC, Cary LA, Jamieson JS, Cooper JA, and Turner CE (2005) Src and FAK kinases cooperate to phosphorylate paxillin kinase linker, stimulate its focal adhesion localization, and regulate cell spreading and protrusiveness. Mol Biol Cell 16:4316-4328. (Pubitemid 41262899)
7. Brunton VG and Frame MC (2008) Src and focal adhesion kinase as therapeutic targets in cancer. Curr Opin Pharmacol 8:427-432.
8. Burridge K, Turner CE, and Romer LH (1992) Tyrosine phosphorylation of paxillin and pp125FAK accompanies cell adhesion to extracellular matrix: a role in cytoskeletal assembly. J Cell Biol 119:893-903.
9. Chodniewicz D and Klemke RL (2004) Regulation of integrin-mediated cellular responses through assembly of a CAS/Crk scaffold. Biochim Biophys Acta 1692:63-76. (Pubitemid 38891768)
10. Choma DP, Milano V, Pumiglia KM, and DiPersio CM (2007) Integrin α3β1- dependent activation of FAK/Src regulates Rac1-mediated keratinocyte polarization on laminin-5. J Invest Dermatol 127:31-40. (Pubitemid 46005658)
11. Deakin NO and Turner CE (2008) Paxillin comes of age. J Cell Sci 121:2435-2444.
12. Eliceiri BP, Paul R, Schwartzberg PL, Hood JD, Leng J, and Cheresh DA (1999) Selective requirement for Src kinases during VEGF-induced angiogenesis and vascular permeability. Mol Cell 4:915-924. (Pubitemid 30054898)
13. Etienne-Manneville S and Hall A (2002) Rho GTPases in cell biology. Nature 420:629-635. (Pubitemid 36764489)
14. Ferrara N (2002) VEGF and the quest for tumour angiogenesis factors. Nat Rev Cancer 2:795-803.
15. Folkman J (2004) Endogenous angiogenesis inhibitors. APMIS 112:496-507.
16. Frisch SM, Vuori K, Ruoslahti E, and Chan-Hui PY (1996) Control of adhesiondependent cell survival by focal adhesion kinase. J Cell Biol 134:793-799. (Pubitemid 26269148)
17. Fukuda I, Ito A, Hirai G, Nishimura S, Kawasaki H, Saitoh H, Kimura K, Sodeoka M, and Yoshida M (2009) Ginkgolic acid inhibits protein SUMOylation by blocking formation of the E1-SUMO intermediate. Chem Biol 16:133-140.
18. Hennequin LF, Allen J, Breed J, Curwen J, Fennell M, Green TP, Lambert-van der Brempt C, Morgentin R, Norman RA, Olivier A, et al. (2006) N-(5-chloro-1,3- benzodioxol-4-yl)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5- (tetrahydro-2H-pyran-4- yloxy)quinazolin-4-amine, a novel, highly selective, orally available, dual-specific c-Src/Abl kinase inhibitor. J Med Chem 49:6465-6488. (Pubitemid 44657442)
19. Hirsch CL, Smith-Windsor EL, and Bonham K (2006) Src family kinase members have a common response to histone deacetylase inhibitors in human colon cancer cells. Int J Cancer 118:547-554. (Pubitemid 43076001)
20. Hood JD and Cheresh DA (2002) Role of integrins in cell invasion and migration. Nat Rev Cancer 2:91-100. (Pubitemid 37328796)
21. Huveneers S and Danen EH (2009) Adhesion signaling - crosstalk between integrins Src and Rho. J Cell Sci 122:1059-1069.
22. Institute of Laboratory Animal Resources (1996) Guide for the Care and Use of Laboratory Animals, 7th ed, Institute of Laboratory Animal Resources, Commission on Life Sciences, National Research Council, Washington DC.
23. Itokawa H, Totsuka N, Nakahara K, Takeya K, Lepoittevin JP, and Asakawa Y (1987) Antitumor principles from Ginkgo biloba L. Chem Pharm Bull (Tokyo) 35:3016-3020.
24. Kim LC, Song L, and Haura EB (2009) Src kinases as therapeutic targets for cancer. Nat Rev Clin Oncol 6:587-595.
25. Kubo I, Kinst-Hori I, and Yokokawa Y (1994) Tyrosinase inhibitors from Anacardium occidentale fruits. J Nat Prod 57:545-551. (Pubitemid 24152917)
26. Kubo J, Lee JR, and Kubo I (1999) Anti-Helicobacter pylori agents from the cashew apple. J Agric Food Chem 47:533-537. (Pubitemid 29185220)
27. Liotta LA, Kleinerman J, and Saidel GM (1974) Quantitative relationships of intravascular tumor cells, tumor vessels, and pulmonary metastases following tumor implantation. Cancer Res 34:997-1004.
28. Liu S, Calderwood DA, and Ginsberg MH (2000) Integrin cytoplasmic domainbinding proteins. J Cell Sci 113 (Pt 20):3563-3571.
29. Liu Y and Senger DR (2004) Matrix-specific activation of Src and Rho initiates capillary morphogenesis of endothelial cells. FASEB J 18:457-468. (Pubitemid 38326302)
30. Mai A, Rotili D, Tarantino D, Ornaghi P, Tosi F, Vicidomini C, Sbardella G, Nebbioso A, Miceli M, Altucci L, et al. (2006) Small-molecule inhibitors of histone acetyltransferase activity: identification and biological properties. J Med Chem 49:6897-6907. (Pubitemid 44749755)
31. Mangieri D, Nico B, Coluccia AM, Vacca A, Ponzoni M, and Ribatti D (2009) An alternative in vivo system for testing angiogenic potential of human neuroblastoma cells. Cancer Lett 277:199-204.
32. McLean GW, Komiyama NH, Serrels B, Asano H, Reynolds L, Conti F, Hodivala- Dilke K, Metzger D, Chambon P, Grant SG, et al. (2004) Specific deletion of focal adhesion kinase suppresses tumor formation and blocks malignant progression. Genes Dev 18:2998-3003. (Pubitemid 39658168)
33. Muroi H and Kubo I (1996) Antibacterial activity of anacardic acid and totarol, alone and in combination with methicillin, against methicillin- resistant Staphylococcus aureus. J Appl Bacteriol 80:387-394.
34. Pang X, Yi T, Yi Z, Cho SG, Qu W, Pinkaew D, Fujise K, and Liu M (2009a) Morelloflavone, a biflavonoid, inhibits tumor angiogenesis by targeting rho GTPases and extracellular signal-regulated kinase signaling pathways. Cancer Res 69:518-525.
35. Pang X, Yi Z, Zhang X, Sung B, Qu W, Lian X, Aggarwal BB, and Liu M (2009b) Acetyl-11-keto-β-boswellic acid inhibits prostate tumor growth by suppressing vascular endothelial growth factor receptor 2-mediated angiogenesis. Cancer Res 69:5893-5900.
36. Patan S (2004) Vasculogenesis and angiogenesis. Cancer Treat Res 117:3-32.
37. Rea AI, Schmidt JM, Setzer WN, Sibanda S, Taylor C, and Gwebu ET (2003) Cytotoxic activity of Ozoroa insignis from Zimbabwe. Fitoterapia 74:732-735. (Pubitemid 37443469)
38. Rogers MS, Birsner AE, and D'Amato RJ (2007) The mouse cornea micropocket angiogenesis assay. Nat Protoc 2:2545-2550.
39. Schenone S, Brullo C, Musumeci F, and Botta M (2010) Novel dual Src/Abl inhibitors for hematologic and solid malignancies. Expert Opin Investig Drugs 19:931-945.
40. Schenone S, Manetti F, and Botta M (2007) SRC inhibitors and angiogenesis. Curr Pharm Des 13:2118-2128. (Pubitemid 47074045)
41. Sun Y, Jiang X, Chen S, and Price BD (2006) Inhibition of histone acetyltransferase activity by anacardic acid sensitizes tumor cells to ionizing radiation. FEBS Lett 580:4353-4356. (Pubitemid 44137349)
42. Sung B, Pandey MK, Ahn KS, Yi T, Chaturvedi MM, Liu M, and Aggarwal BB (2008) Anacardic acid (6-nonadecyl salicylic acid), an inhibitor of histone acetyltransferase, suppresses expression of nuclear factor-κB-regulated gene products involved in cell survival, proliferation, invasion, and inflammation through inhibition of the inhibitory subunit of nuclear factor-κBα kinase, leading to potentiation of apoptosis. Blood 111:4880-4891.
43. Timpson P, Jones GE, Frame MC, and Brunton VG (2001) Coordination of cell polarization and migration by the Rho family GTPases requires Src tyrosine kinase activity. Curr Biol 11:1836-1846. (Pubitemid 33136523)
44. Toyomizu M, Okamoto K, Ishibashi T, Chen Z, and Nakatsu T (2000) Uncoupling effect of anacardic acids from cashew nut shell oil on oxidative phosphorylation of rat liver mitochondria. Life Sci 66:229-234. (Pubitemid 30025474)
45. Tozer GM, Kanthou C, and Baguley BC (2005) Disrupting tumour blood vessels. Nat Rev Cancer 5:423-435. (Pubitemid 40791485)
46. Trevisan MT, Pfundstein B, Haubner R, Wü rtele G, Spiegelhalder B, Bartsch H, and Owen RW (2006) Characterization of alkyl phenols in cashew (Anacardium occidentale) products and assay of their antioxidant capacity. Food Chem Toxicol 44:188-197. (Pubitemid 41773813)
47. Yi T, Yi Z, Cho SG, Luo J, Pandey MK, Aggarwal BB, and Liu M (2008) Gambogic acid inhibits angiogenesis and prostate tumor growth by suppressing vascular endothelial growth factor receptor 2 signaling. Cancer Res 68:1843-1850. (Pubitemid 351416570)
48. Ziche M and Morbidelli L (2009) The corneal pocket assay. Methods Mol Biol 467:319-329.